BREAST-MILK JAUNDICE - INVITRO INHIBITION OF RAT-LIVER BILIRUBIN-URIDINE DIPHOSPHATE GLUCURONYLTRANSFERASE ACTIVITY AND Z-PROTEIN-BROMOSULFOPHTHALEIN BINDING BY HUMAN BREAST-MILK
BREAST-MILK JAUNDICE - INVITRO INHIBITION OF RAT-LIVER BILIRUBIN-URIDINE DIPHOSPHATE GLUCURONYLTRANSFERASE ACTIVITY AND Z-PROTEIN-BROMOSULFOPHTHALEIN BINDING BY HUMAN BREAST-MILK
复制标题
DOI:
10.1203/00006450-197606000-00007
复制
发表时间:
1976-01-01
影响因子:
3.6
通讯作者:
ODIEVRE, M
中科院分区:
文献类型:
--
作者:
FOLIOT, A;PLOUSSARD, JP;ODIEVRE, M
Twenty-four samples of breast milk from 9 mothers of infants suffering from breast milk jaundice were studied. Eight samples of milk from mothers of nonjaundiced infants, along with 5 formula milks enriched with polyunsaturated fatty acids, served as controls. Milks from mothers with jaundiced infants had no inhibitory effect when assayed immediately after thawing. After these milk samples were stored at 4.degree., they strongly inhibited bilirubin conjugation (80.3% inhibition of uridine diphosphate glucuronyltransferase (UDPGT) activity) and bromosulfophthalein (BSP) binding to cytoplasmic Z protein (dye binding inhibited 82.1%). There was no effect on BSP binding to Y protein. Heating the milk to 56.degree. modified the results in the following manner. When the milk was heated immediately after thawing, no inhibitory effect was seen, even after storage for 96 h. When the milk was 1st stored at 96 h and then heated, it had the same inhibitory effects as the milks which were stored without heating. Pathologic breast milk will apparently inhibit BSP-Z protein binding only when stored under conditions that also cause the appearance of the capacity to inhibit bilirubin conjugation in vitro, as well as causing the liberation of nonesterified fatty acids. The appearance of this inhibitory capacity in vitro seems linked to the lipolytic activity particular to pathologic milks.